Slinda Drospirenone 4mg Progestogen-Only Oral Contraceptive Tablets 28s

• Drospirenone 4 mg film-coated tablets (28 active tablets – no placebo) • New-generation progestogen-only pill (POP) – the first estrogen-free oral contraceptive with a 24+4 regimen • Highly effective (Pearl Index 0.4) with 24-hour missed-pill window • Prescription-only medicine • Pack contains 28 tablets (one month cycle)

Slinda 4 mg Tablets contain drospirenone, a fourth-generation progestogen with anti-mineralocorticoid and anti-androgenic properties. Taken daily for 24 days (white active tablets) followed by 4 days of green placebo tablets, it provides reliable contraception while offering a more flexible 24-hour missed-pill window than traditional POPs. Additional benefits include reduced menstrual bleeding (30–50% of women become amenorrhoeic) and improvement in acne and hirsutism. Benefits • Estrogen-free – suitable for women who cannot take combined pills (breastfeeding, migraine with aura, thrombosis risk, >35 and smoking, etc.) • 24-hour missed-pill window (most forgiving POP) • Often lighter or no periods + relief from heavy menstrual bleeding • Anti-androgenic – helps acne, hirsutism, and PCOS symptoms • Low risk of weight gain and mood changes compared to older POPs • No scheduled bleeding break needed How to Use • Take 1 tablet daily at the same time (24 white active + 4 green placebo) • Start on day 1 of cycle (no additional contraception needed) or any day with 7-day backup if switching • If a white tablet is missed 24 hours late → take last missed tablet, use condoms for next 7 days • Vomiting/diarrhoea within 4 hours → take another tablet • No tablet-free week – start next pack immediately after last green tablet